Bioc Pharmaceuticals Private Limited

Trastuzumab is an injectable medication used to treat certain types of breast and stomach cancers that are "HER2-positive". It is a targeted therapy, which works by attaching to the HER2 protein on cancer cells, blocking their growth signals, and prompting the immune system to destroy them. 

GEMIBINE 200
Each vial contains:
Gemcitabine Hydrochloride IP equivalent to Gemcitabine ...200 mg
Excipients...q.s.
Dose: As directed by the Physician.
Store at room temperature. (15°C to 30°C).
DO NOT REFRIGERATE
Warning: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of Cancer Specialists.
SCHEDULE H PRESCRIPTION DRUG-CAUTION
Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Caution: Gemcitabine Hydrochloride is cytotoxic; Extra care required to prevent inhaling and exposing the skin to it.
Reconstitution: To reconstitute add
at least 5 ml of 0.9% Sodium Chloride Injection (without preservative) to the 200 mg vial to make a solution containing not greater than 40 mg/ml. Shake to dissolve.
Discard unused portion.

ALRUBICIN 100
Epirubicin injection is used together with other cancer medicines to treat breast cancer in patients who have had surgery to remove the tumor. Epirubicin belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed.

• Store between 2 deg C to 8 deg C. Do not freeze. 
• Keep vial in outer carton to protect from light. 
• Keep out of reach and sight of children. 
• For IV infusion after dilution 

Rituximab is a monoclonal antibody medication primarily used to treat certain types of cancer and autoimmune diseases. It works by targeting and binding to the CD20 protein found on B cells, a type of white blood cell, which can help the immune system eliminate these cells.

• Docetaxel IP 20 mg
• Polysorbate 80 IP (Purified) 520 mg
• Citric Acid IP q.s to adjust pH
• Dehydrated Alcohol IP q.s. to 1 ml

• For I.V. infusion after dilution 
• Contains no antimicrobial preservatives

• Single use vial
• Discard unused contents appropriately.
• Store at a temperature not exceeding 25°C. Keep out of the reach of the children. 
• Dosage: As directed by the Physician. 
• Cytotoxic Agent

• Carboplatin IP 10 mg
• Water for Injection IP  q.s. 

• Contains no preservatives
• For I.V. Infusion after dilution
• Single dose vial
• Dosage: As directed by the Physician.
• Read accompanying package insert for detailed dosage, directions for use and precautions. 
• Store at 15° - 30° C.
• Store protected from light and free from contact with metals. 
• Handle the injection with great care since it is a potent cyto-toxic agent. 

TEMOSTED 250
Temozolomide is used to treat certain types of brain tumors. Temozolomide is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

GEMCITE
Indications, dosage and administration: See package insert
Composition: Each vial contains: Gemcitabine Hydrochloride I.P. equivalent to 1g Gemcitabine as active ingredient, 1g Mannitol I.P. as stabilizer, 62.5mg Sodium Acetate I.P. as buffering agent and Hydrochloric Acid Solution I.P. (10%) and/or Sodium Hydroxide Solution I.P. (10%) may be added for pH adjustment, Water for Injection I.P. q.s. 25ml.
To reconstitute: Add 25 mL of 0.9% Sodium Chloride Injection (without preservative) to the 1 g vial. Shake to dissolve. This dilution yields a gemcitabine concentration of 38 mg/mL. The total volume after reconstitution is 26.3 mL. Further dilution with sterile sodium chloride solution 9 mg/mL can be done.
Storage: Unopened vials should be stored at room temperature (below 30°C).
Reconstituted solutions of Gemcite are stable for 24 hours at room temperature. Solutions of reconstituted Gemcite should not be refrigerated, as crystallization may occur.
SCHEDULE H DRUG: CAUTION
To be sold on the Prescription of Oncologists only
Discard unused portion. 
Caution: Cytotoxic Agent
Manufactured by:
LILLY FRANCE S.A.S, Centre de Production, 2, Rue Du Colonel Lilly, Zone Industrielle, F-67640, Fegersheim, France
Imported By:
Eli Lilly and Company (India) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1st Fl, Arihant Comm. Complex, Purna Bhiwandi, Maharashtra-421302
Marketed By:
Eli Lilly and Company (India) Pvt. Ltd., Plot No. 92, Sector 32, Gurgaon, Haryana, India

• Ovarian Cancer: Paclitaxel is used to treat advanced ovarian cancer, both as a first-line and subsequent therapy. 
• Breast Cancer: It is used to treat breast cancer, including adjuvant (after surgery) treatment and metastatic disease. 
• Non-Small Cell Lung Cancer (NSCLC): Paclitaxel is indicated for the treatment of NSCLC. 
• Kaposi Sarcoma: It is used to treat Kaposi sarcoma, particularly in patients with AIDS. 
• Other Cancers: Paclitaxel may also be used to treat other solid tumors. 

• Ovarian Cancer: Paclitaxel is used to treat advanced ovarian cancer, both as a first-line and subsequent therapy. 
• Breast Cancer: It is used to treat breast cancer, including adjuvant (after surgery) treatment and metastatic disease. 
• Non-Small Cell Lung Cancer (NSCLC): Paclitaxel is indicated for the treatment of NSCLC. 
• Kaposi Sarcoma: It is used to treat Kaposi sarcoma, particularly in patients with AIDS. 
• Other Cancers: Paclitaxel may also be used to treat other solid tumors. 

Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.

Methotrexate is in a class of medications called antimetabolites. Methotrexate treats cancer by slowing the growth of cancer cells. Methotrexate treats psoriasis by slowing the growth of skin cells to stop scales from forming.